“Big Pharma”—A Name That Often Hides a More Complicated Story

by Rev. Richard Dalton creator of LookUpDetroit.com

The expression “Big Pharma” has become one of the most common labels in public discussion. It is usually spoken with suspicion, sometimes with anger, and often as a shorthand for greed or corporate influence. Like many labels, however, it can oversimplify a much more complicated reality.

When I hear the phrase, I remind myself that behind it are thousands of scientists, physicians, laboratory technicians, engineers, nurses, statisticians, manufacturers, and researchers who have devoted their lives to fighting disease. While corporations deserve scrutiny—as every large institution does—it is also important to recognize the extraordinary good that pharmaceutical research has accomplished.

A century ago, many illnesses that we barely think about today were often death sentences. Simple infections claimed countless lives. Childhood diseases devastated families. Diabetes was almost always fatal before insulin became available. Pneumonia, tuberculosis, and many bacterial infections frequently ended in tragedy.

Medical research changed that.

The discovery and development of antibiotics transformed modern medicine. Vaccines have dramatically reduced or eliminated diseases such as smallpox and greatly reduced illnesses like polio in many parts of the world. Improved medications have allowed millions to live longer with heart disease, high blood pressure, asthma, epilepsy, HIV, and many forms of cancer.

Organ transplantation, a subject close to my own heart as a liver transplant recipient, would hardly be possible without sophisticated medications that help prevent organ rejection. These drugs have given countless people years—even decades—of additional life with their families.

The story of pharmaceutical innovation is also the story of persistence. Developing a single new medicine often requires years of laboratory work, animal studies, multiple phases of human clinical trials, regulatory review, and billions of dollars in investment. Most potential medicines never reach the pharmacy shelf because they prove ineffective or unsafe during development.

That doesn’t mean the industry is beyond criticism.

Like banking, technology, media, government, education, or healthcare itself, pharmaceutical companies are operated by imperfect human beings. There have been pricing controversies, aggressive marketing campaigns, lawsuits, recalls, failures to disclose important information, and cases where profits appeared to overshadow patients. The opioid crisis, for example, demonstrated how devastating the consequences can be when incentives become misaligned with public health.

These failures deserve investigation, accountability, and reform.

But criticism should not erase gratitude.

Many researchers spend their entire careers searching for treatments for Alzheimer’s disease, ALS, Parkinson’s disease, childhood cancers, rare genetic disorders, and countless other conditions that bring enormous suffering. Most of these individuals will never become famous, yet their work quietly improves millions of lives.

I also think the phrase “Big Pharma” itself deserves examination. We don’t usually speak about “Big Aviation” when airplanes safely transport millions of passengers. We don’t often say “Big Agriculture” when discussing food production. The label has become emotionally charged, making it easier to view an entire industry through one negative lens.

As Christians—and simply as thoughtful citizens—we should resist easy labels. Scripture repeatedly encourages discernment, truthful judgment, and fairness. That means neither assuming that every pharmaceutical company is motivated solely by greed nor imagining that every decision made by the industry is automatically wise or beyond question.

Instead, we should seek evidence, welcome honest debate, encourage transparency, support ethical medical research, and pray for wisdom for those making decisions that affect human life.

The goal should never be blind trust or automatic suspicion.

The goal should be truth.

Medical science has relieved suffering on a scale that earlier generations could scarcely imagine. At the same time, every powerful institution benefits from public accountability and moral responsibility.

Perhaps that is the healthiest way to think about what people call “Big Pharma.” It is not one villain, nor one hero. It is a vast collection of organizations and people capable of remarkable compassion, astonishing scientific achievement, costly mistakes, and continual improvement.

Instead of reducing the conversation to slogans, let’s ask better questions. Let’s recognize genuine accomplishments, confront genuine failures, and remember that behind every medicine is ultimately a human story—a patient hoping for healing, a family praying for more time, and researchers striving to make tomorrow healthier than yesterday. – Richard – Grateful Liver Transplant Patient